Quantification of classical swine fever virus load by one-step TaqMan real-time RT-PCR assay

315-322A fluorogenic-probe hydrolysis (TaqMan) real-time reverse transcriptase polymerase chain reaction (RT-PCR) assay based on amplification of a 93 bp fragment from 5’un-translated region (5’UTR) of classical swine fever virus was used for detection and absolute quantification of the virus in clinical and tissue samples. For determining analytical sensitivity, an in vitro transcript RNA containing 5’UTR of classical swine fever virus (CSFV) strain Alfort187 from plasmid pCRXLV324-6 was used as a positive control and a standard for quantification of CSFV genomic RNA copies. The real-time quantitative RT-PCR (qRT-PCR) assay was used to assess the CSFV shedding from naturally infected pigs in whole blood, nasal swab and also in tissue samples. Used qRT-PCR was specific and sensitive as it could detect as low as 16.3 copies of CSFV genomic RNA. The assay was also reproducible as shown by satisfactory low intra-assay (0.80 % to 1.87 %) and inter-assay (1.00% to 3.80%) coefficient of variation with an efficiency of 102.3% and R2 of 0.993. Thus, the real-time qRT-PCR assay described here allows rapid, specific and sensitive laboratory detection and quantification of CSFV genomic RNA copies

Reiterating the Emergence of Noncoding RNAs as Regulators of the Critical Hallmarks of Gall Bladder Cancer

Gall bladder cancer (GBC) is a rare and one of the most aggressive types of malignancies, often associated with a poor prognosis and survival. It is a highly metastatic cancer and is often not diagnosed at the initial stages, which contributes to a poor survival rate of patients. The poor diagnosis and chemoresistance associated with the disease limit the scope of the currently available surgical and nonsurgical treatment modalities. Thus, there is a need to explore novel therapeutic targets and biomarkers that will help relieve the severity of the disease and lead to advanced therapeutic strategies. Accumulating evidence has correlated the atypical expression of various noncoding RNAs (ncRNAs), including circular RNAs (circRNAs), long noncoding RNAs (lncRNAs), microRNAs (miRNAs), and small nucleolar RNAs (snoRNA) with the increased cell proliferation, epithelial–mesenchymal transition (EMT), invasion, migration, metastasis, chemoresistance, and decreased apoptosis in GBC. Numerous reports have indicated that the dysregulated expression of ncRNAs is associated with poor prognosis and lower disease-free and overall survival in GBC patients. These reports suggest that ncRNAs might be considered novel diagnostic and prognostic markers for the management of GBC. The present review recapitulates the association of various ncRNAs in the initiation and progression of GBC and the development of novel therapeutic strategies by exploring their functional and regulatory role